US Broker Ratings

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Exploring a 15% Potential Upside with Robust Revenue Growth

BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands out in the healthcare sector as a promising player in the biotechnology industry. With its innovative approach to developing transformative..

Alcon Inc. (ALC) Stock Analysis: Eyeing a 14.34% Upside in the Global Eye Care Market

Alcon Inc. (NYSE: ALC), a leading player in the healthcare sector, focuses on pioneering eye care solutions that span the globe. As a key entity in..

Tempus AI, Inc. (TEM) Stock Analysis: A Healthcare Tech Powerhouse with 34.59% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM) stands at the forefront of innovation in the healthcare sector, leveraging cutting-edge technology to deliver advanced diagnostic and analytical solutions. With..

GSK plc (GSK) Investor Outlook: Evaluating a 5.75% Upside Potential in the Healthcare Giant

GSK plc (GSK), a venerable name in the healthcare sector, stands as a formidable player within the global drug manufacturing industry. With a market capitalization of..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Marvel with 16% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND) stands out in the biotechnology sector with its innovative approach to addressing unmet medical needs through TransCon-based therapies. As the healthcare..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating Growth in the Diagnostics Sector with a 4.25% Upside

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a formidable entity in the healthcare sector, particularly within the Diagnostics & Research industry. With a market capitalization..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a 4.66% Potential Upside Amidst Industry Challenges

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a significant player in the global pharmaceutical industry, offering a diverse portfolio that spans across generic medications, active..

DaVita Inc. (DVA) Investor Outlook: Unpacking a 32% Potential Upside Amidst Healthcare Challenges

DaVita Inc. (NYSE: DVA), a leading player in the healthcare sector, specifically within the medical care facilities industry, presents a mixed yet intriguing opportunity for investors...

Cooper Companies, Inc. (COO) Investor Outlook: Navigating a 12% Upside Potential in Healthcare

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, has garnered significant attention from investors seeking opportunities in the medical instruments and..

Revvity, Inc. (RVTY) Stock Analysis: Navigating the Healthcare Diagnostics Landscape with a $13.55 Billion Market Cap

Revvity, Inc. (RVTY), a stalwart in the healthcare diagnostics and research industry, offers a diverse range of health sciences solutions, technologies, and services. With a market..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 26.3% Potential Upside Amidst Strong Growth Metrics

AptarGroup, Inc. (NYSE: ATR) is capturing investor attention with its robust market position in the healthcare sector, particularly within the medical instruments and supplies industry. With..

Royalty Pharma plc (RPRX) Stock Analysis: Unveiling a Promising 15.47% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biotechnology sector as a unique player with a business model focused on acquiring biopharmaceutical royalties and funding..

Veeva Systems Inc. (VEEV) Stock Analysis: Unpacking a Potential 39% Upside for Investors

Veeva Systems Inc. (NYSE: VEEV), a stalwart in the healthcare technology sector, is capturing investor attention with its robust market presence and promising growth metrics. With..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Exploring a 35.69% Potential Upside in the Biotech Sector

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnological space, has garnered significant attention due to its promising pipeline of therapeutics based on ribonucleic acid..

Moderna, Inc. (MRNA) Stock Analysis: Navigating the Challenges Amidst a -45% Revenue Decline

Moderna, Inc. (NASDAQ: MRNA), a prominent player in the biotechnology sector, has captured the attention of investors worldwide with its innovative mRNA technology. However, recent financial..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Unveiling a 10.98% Upside Potential in Healthcare

IQVIA Holdings, Inc. (NYSE: IQV), a titan in the healthcare sector, particularly in diagnostics and research, is making waves with its robust market presence and promising..

Masimo Corporation (MASI)

⚠️ No article content returned.

..

Glaukos Corporation (GKOS) Stock Analysis: Navigating the Glaucoma Therapy Market with a 9% Potential Upside

Glaukos Corporation (NYSE: GKOS) stands at the forefront of ophthalmic pharmaceuticals and medical technology, carving a niche in the treatment of glaucoma, corneal disorders, and retinal..

Exact Sciences Corporation (EXAS) Stock Analysis: Riding the Healthcare Wave with a 3.47% Upside

Exact Sciences Corporation (NASDAQ: EXAS) stands as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of..

Neurocrine Biosciences, Inc. (NBIX): Investor Outlook on a 31.63% Potential Upside

For investors keen on the healthcare sector, Neurocrine Biosciences, Inc. (NBIX) presents a compelling opportunity, especially with a significant 31.63% potential upside based on analyst ratings...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds